Revaprazan
From Infogalactic: the planetary knowledge core
File:Revaprazan.svg | |
Systematic (IUPAC) name | |
---|---|
N-(4-Fluorophenyl)-4,5-dimethyl-6-(1-methyl-3,4-dihydro-2(1H)-isoquinolinyl)-2-pyrimidinamine
|
|
Clinical data | |
Trade names | Revanex[1] |
Identifiers | |
CAS Number | 199463-33-7 |
ATC code | None |
PubChem | CID: 204104 |
ChemSpider | 176801 |
Synonyms | YH1885 |
Chemical data | |
Formula | C22H23FN4 |
Molecular mass | 362.44 g/mol |
|
|
|
Revaprazan (trade name Revanex) is a drug that reduces gastric acid secretion which is used for the treatment of gastritis.[2] It acts as an acid pump antagonist[3] (potassium-competitive acid blocker). Revaprazan is approved for use in Korea,[4] but is not approved in Europe or the United States.
References
<templatestyles src="Reflist/styles.css" />
Cite error: Invalid <references>
tag; parameter "group" is allowed only.
<references />
, or <references group="..." />
<templatestyles src="Asbox/styles.css"></templatestyles>
Categories:
- Pages with reference errors
- Pages with broken file links
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Proton pump inhibitors
- Anilines
- Organofluorides
- Pyrimidines
- Tetrahydroisoquinolines
- Gastrointestinal system drug stubs